|Last Price$0.02||Day Change (%)0.00%|
|Open Price$0.02||Day Change ($)0.00|
|Day Range0.02–0.02||52-Week Range0.01–1.00|
As of Fri 5/22/2015 12:24:00 PM | USD
IMS Health Announces Pricing of Secondary Public Offering and Repurchase of Common Stock
IMS Health Finds Global Cancer Drug Spending Crossed $100 Billion Threshold in 2014
Mylan Confirms First-to-File Patent Challenge Relating to Minivelle®
Mylan Launches Generic Seasonale® Tablets
Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.
IMS Health is on the right track for growth.
A look back at the winners and losers of the final quarter of a tumultuous year.